Jun Liang
Zhengzhou University of Light Industry(CN)Zhengzhou University(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology
Most-Cited Works
- → Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial(2011)119 cited
- → Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)(2016)70 cited
- → A comparative analysis of infection in patients with malignant cancer: A clinical pharmacist consultation study(2019)17 cited
- → Case Report: Complete Remission With Anti−PD−1 and Anti−VEGF Combined Therapy of a Patient With Metastatic Primary Splenic Angiosarcoma(2022)16 cited
- → ERCC1 Asn118Asn polymorphism as predictor for cancer response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer(2008)7 cited
- → Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy(2021)7 cited